A reduction in circulating adiponectin in obese pregnancy is also associated with the development of GDM and may impact on the adaptive increase in BCM and function, since adiponectin has been shown to increase beta-cell proliferation in mouse islets (83). The gene discussed is ADIPOQ; the disease is gestational diabetes.